{"id":887102,"date":[{"year":1992,"month":10,"day":31}],"page":"3","source":"本报","region":"","masthead":"科教文卫新闻","special_issue":"","column":"","genre":"","count":"220","ytitle":"诊治乙型肝炎有新药","mtitle":"“澳泰乐”临床疗效好","ftitle":"","authors":[],"text":[{"type":"paragraph","text":"本报讯　上海第二医科大学附属第九人民医院内科应用吉林省敦化市制药厂生产的治疗乙型肝炎新药——澳泰乐冲剂临床疗效观察显示，该药临床症状好转达77.08%，肝功能指标基本恢复正常，澳抗原转阴率达40.62%，且无任何副作用。该药是由长春中医学院附属医院任继学教授经十多年临床验证，并首次发现和利用长白山地区的返魂草中药而研制成功的。据悉:该药已作为临床用药，市卫生局已批准列入公费、劳保报销范围。"}]}